Hematological and hepatic alterations as predictors of mortality in patients hospitalized by SARS-COV-2
A. Rios-Pereda (Mexico City, Mexico), A. Orea-Tejeda (Mexico City, Mexico), D. Gonzalez-Islas (Mexico City, Mexico), J. Aguilar-Meza (Mexico City, Mexico), C. Marquez-Cordero (Mexico City, Mexico), L. Cornejo-Cornejo (Mexico City, Mexico), M. Salvatiera-Escobar (Mexico City, Mexico), I. Lopez-Vazquez (Mexico City, Mexico), C. Sanchez-Moreno (Mexico City, Mexico), J. Orozco-Gutierrez (Mexico City, Mexico), B. Valderrabano-Salas (Mexico City, Mexico), R. Robles-Hernandez (Mexico City, Mexico), R. Hernandez-Zenteno (Mexico City, Mexico), A. Jimenez-Valentin (Mexico City, Mexico), M. Salgado-Fernandez (Mexico City, Mexico), L. Cornejo-Cornejo (México City, Mexico)
Source: International Congress 2022 – Biomarkers in COVID-19
Session: Biomarkers in COVID-19
Session type: Thematic Poster
Number: 864
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Rios-Pereda (Mexico City, Mexico), A. Orea-Tejeda (Mexico City, Mexico), D. Gonzalez-Islas (Mexico City, Mexico), J. Aguilar-Meza (Mexico City, Mexico), C. Marquez-Cordero (Mexico City, Mexico), L. Cornejo-Cornejo (Mexico City, Mexico), M. Salvatiera-Escobar (Mexico City, Mexico), I. Lopez-Vazquez (Mexico City, Mexico), C. Sanchez-Moreno (Mexico City, Mexico), J. Orozco-Gutierrez (Mexico City, Mexico), B. Valderrabano-Salas (Mexico City, Mexico), R. Robles-Hernandez (Mexico City, Mexico), R. Hernandez-Zenteno (Mexico City, Mexico), A. Jimenez-Valentin (Mexico City, Mexico), M. Salgado-Fernandez (Mexico City, Mexico), L. Cornejo-Cornejo (México City, Mexico). Hematological and hepatic alterations as predictors of mortality in patients hospitalized by SARS-COV-2. 864
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|